- In December 2024, Merck KGaA announced the closing of its acquisition of HUB Organoids Holding B.V. (HUB). This strategic acquisition aims to expand Merck's next-generation biology portfolio and reinforces its commitment to providing novel solutions that enable faster and more effective drug development, integrating organoid technology with its cell culture portfolio
- In September 2023, Sigma-Aldrich announced an investment to boost its research facilities in Mumbai, India. This move is expected to enhance local production capabilities for various life science products, including cell culture media, to cater to the growing Indian market
- In August 2023, Corning launched Videodrop, an optical technology that applies the principles of interferometric microscopy to quantify the size and concentration of nanoparticles. While not exclusively cell culture media, this technology is a valuable addition to bioprocessing, improving real-time analysis of cell culture components and formulations
- In July 2023, Sartorius opened a 21,500 square-foot cell culture media manufacturing plant at its existing Yauco, Puerto Rico site. This expansion signifies Sartorius' commitment to increasing production capacity for cell culture media to meet growing global demand
- In April 2023, AnaBios, a preclinical contract research organization, acquired Cell Systems, a human primary cell and cell culture media provider. This acquisition aimed to expand AnaBios portfolio of human tissue and cells, thereby strengthening its product pipeline for drug discovery and understanding cell biology
